Association Between ω‐3, ω‐6 Polyunsaturated Fatty Acid and Sleep Disorders: From Cross‐Sectional to Mendelian Randomization Studies
Abstract
ABSTRACT Sleep disorders are a common health problem affecting a significant proportion of the adult population. Emerging evidence suggests that dietary factors, particularly polyunsaturated fatty acid (PUFA) intake, may play a role in modulating sleep quality. This study aims to investigate the association between omega‐3 (ω‐3) and omega‐6 (ω‐6) PUFA and sleep disorders using cross‐sectional survey data and data from genome‐wide association studies (GWAS). Using data from the National Health and Nutrition Examination Survey (NHANES, 2005–2018), we analyzed a cohort of 31,920 participants, with the primary independent variables being intake of ω‐3 and ω‐6 PUFAs. Multivariate regression was used to assess associations, and restricted cubic spline analysis was used to explore potential non‐linear dose–response relationships. Two‐sample Mendelian randomization (MR) analyses were performed to evaluate the causal effects of levels of multiple fatty acids on the risk of sleep disorders. For analysis on NHANES data, the participants with sleep disorders had significantly lower ω‐3 PUFA intake (1.71 ± 1.11 g) compared to those without sleep disorders (1.78 ± 1.14 g, p < 0.001). Regression analysis revealed that higher ω‐3 PUFA intake was associated with a reduced risk of sleep disorders, while the MR analyses showed that a higher ratio of ω‐6 to total fatty acid levels was causally associated with a lower risk of sleep disorders (IVW OR = 0.930, 95% CI: 0.880–0.983, p = 0.011). Our…
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.